Compare · 2 funds side by side · dividends reinvested

IHE and IDNA

IHEiShares×IDNAiShares×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$18,460IHE · best of the two

02 / 04

IHE and IDNA, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares U.S. Pharmaceuticals ETFSectors · Health care0.37%1.36%+25.6%+41.2%+25.7%+13.0%−9.7%19.0%$1.7B1.4

iShares Genomics Immunology and Healthcare ETFSectors · Health care0.47%0.68%+58.8%+70.0%+33.2%−2.8%−10.6%30.6%$354M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: IHE 2006 · IDNA 2019

Head to Head

Swap sides Versus in desk

Head to Head

iShares U.S. Pharmaceuticals ETF · $1.7B$18,460

IHE

IDNA

iShares Genomics Immunology and Healthcare ETF · $354M$8,654

$10,000 five years ago, dividends reinvested · they hold 3.6% in common

IHEMeasureIDNA

+25.6%Year to dateJan 1 → Nov 5+58.8%

+41.2%1 yearTotal return+70.0%

+25.7%3 years · per year$10,000 became $19,844 · $23,655+33.2%

+13.0%5 years · per year$10,000 became $18,460 · $8,654−2.8%

0.37%Expense ratio$37 · $47 a year on $10k · lower is better0.47%

1.36%Trailing 12-mo yield$136 · $68 a year on $10k0.68%

−9.7%Worst dropSmaller is better−10.6%

19.0%VolatilityLower is calmer30.6%

IHEIDNA Winner of the row, in its colourEach row: the bigger of the two fills its side

5–3IHE wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IHE vs IDNA: Top 5 Holdings

Today

IHE

62.8%in top 5

IDNA

in top 533.8%

IHEStockIDNA

26.5%LLYnot top 5

21.8%JNJnot top 5

not top 5MRNA14.6%

not top 5GMAB.CO5.8%

not top 5TWST5.5%

5.1%ZTSnot top 5

4.7%RPRXnot top 5

4.7%PFEnot top 5

not top 5REGN3.9%

not top 5BAYN.DE3.9%

Held in common3.6%

End-of-day Nov 5, 2026 · share of each fund

IHE vs IDNA Returns, Every Period

iSharesIHE

+13.0%

5 years, per year

IDNAiShares

−2.8%

5 years, per year

IHEIDNAFaded: behind in that period

1–3IDNA wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

IHE vs IDNA

YTD

iSharesIHE

+25.6%

IDNAiShares

+58.8%

+25.6%Year to date+58.8%

−9.7%Worst drop · 1Y−10.6%

19.0%Volatility · 1Y30.6%

1.4%Yield0.7%

$1.7BAssets$354M

3–1IHE wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IHE, IDNA

Today

0.37%lowest, IHE

FundExpense ratioFee$10k

IHE0.37%$37

IDNA0.47%$47

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: IHE, IDNA

1.36%highest, IHE

FundTrailing yieldYield$10k

IHE1.36%$136

IDNA0.68%$68

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$99most kept, IHE

IHE$136 − $37 = $99

IDNA$68 − $47 = $21

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: IHE, IDNA

Today

3.6%most shared, IHE and IDNA

IHEIDNA

IHE—3.6%

IDNA3.6%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+70.0%IDNA, at 30.6% volatility

IHEWorst drop−9.7%19.0% vol

IDNAWorst drop−10.6%30.6% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

IHEIDNA

+25.6%Year to date+58.8%

1.4%Yield0.7%

+41.2%Past year+70.0%

0.37%Fee0.47%

2–2level

End-of-day Nov 5, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.1BAssets$46.1B

2–0JEPQ wins

End-of-day Nov 5, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.4%

SPYSPDR

+8.3%

+8.4%Year to date+8.3%

1.1%Yield1.0%

$182BAssets$805B

2–0SPYM wins

End-of-day Nov 5, 2026